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Cutaneous Pseudolymphoma Derived from Ruptured Milia
Minseok Lee, Jemin Kim, Do Young Kim
Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, 
Korea
Dear Editor:
Cutaneous pseudolymphoma (CPL) is an inflammatory 
condition described as a heterogeneous group of benign 
reactive T-cell or B-cell lymphoproliferative processes of 
diverse causes1. CPL has been associated with variable 
causes such as drugs, trauma, infections, inflammatory 
dermatoses, and reaction to foreign antigens introduced 
by arthropod bites, stings, infestation, tattoos, and vacci-
nations2,3. Although most cases are idiopathic, these asso-
ciations suggest that CPL may be a reactive response to 
newly encountered antigens4. Here, we report a case of 
recurrent CPL derived from the rupture of multiple milia 
on the face.
A 72-year old woman presented with multiple confluent 
erythematous plaques on the forehead and left side of her 
face of 6-years duration (Fig. 1A). The patient had a medi-
cal history of hypertension although both clinical exami-
nation and blood test findings were otherwise 
unremarkable. She had no other symptoms such as fever, 
or history of recent travel, localised trauma, medication in-
take, or insect bites. Histologic examination of punch bi-
opsy specimens taken from the plaques on her forehead 
revealed lymphoid nodules consisting of dense mixed 
lymphocytic infiltrates (Fig. 2A). Infiltrating cells were pre-
dominantly mixed with CD20 expressing cells and CD3 
expressing cells (Supplementary Fig. 1A, B). The cells 
were focally positive for BCL2 and BCL6; CD43 was ex-
pressed only by T lymphocytes (Supplementary Fig. 1C∼
E). On the basis of the histological findings, a diagnosis of 
CPL was suggested. The patient was treated with oral pre-
dnisolone and topical steroids, and the lesions temporarily 
subsided. However, the lesions recurred, and upon closer 
examination, multiple milia were found within the lesions 
(Fig. 1B). Another biopsy was performed to capture the 
new lesions that included milia; histopathology showed 
dense lymphocytic infiltration recognizably derived from 
ruptured milia (Fig. 2B).
Based on the above findings, a new diagnosis of milium 
with pseudolymphoma was made. The lesions markedly 
subsided with oral prednisolone and intra-lesional tri-
amcinolone injections. However, on subsequent fol-
low-up, the lesions returned and were distributed around 
the site of recurrent milia. Thus, the milia were extracted, 
and the recurrence of CPL remarkably subsided. Subse-
quently, the symptoms were well-controlled with oral cy-
closporine and intra-lesional injections of triamcinolone 
(Fig. 1C).
CPL has a wide range of presentations and histological 
features that may be misinterpreted clinically and histolog-
ically as cutaneous lymphomas.
In our case, the lesions were distributed within areas of 
milia; the histopathological findings of lymphocytic in-
filtrations along the ruptured milia suggested that CPL 
arose from the ruptured milia. In addition, by treating the 
milia, the CPL lesions improved and the recurrences were 
markedly reduced, which further indicated their asso-
ciation. 
It was reported that persistent stimulation caused by nod-
ular scabies, arthropod bites, and retained foreign materi-
als can promote chronic antigenic reactions5. Similarly, 
keratin protein from the ruptured milia may act as an anti-
gen that causes a persistent reaction, subsequently leading 
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Fig. 1. Clinical characteristics. (A) 
Initial clinical presentation of 
patient. Multiple confluent erythe-
matous plaques on the forehead 
and left side of her face; (B) 
Recurrence of erythematous pla-
ques with multiple milia found 
within the lesions; (C) Significant 
improvement of the lesions after 
the extraction of milia. We 
received the patient’s consent form 
about publishing all photographic 
materials.
Fig. 2. Histological findings. (A) Histological examination shows lymphoid nodules consisting of dense mixed lymphocytic infiltrates 
(H&E; left, ×40 and right, ×200 magnification). (B) Histologic examination showing dense lymphocytic infiltration visibly derived 
from rupture of milia (H&E, ×40 magnification).
to the development of CPL.
To our knowledge, this is the first case report of CPL asso-
ciated with milia although further studies are necessary. 
Spontaneous resolution of CPL may be induced by elimi-
nation of the underlying skin pathology which can be a 
persistent antigenic stimulus.
SUPPLEMENTARY MATERIALS
Supplementary data can be found via http://anndermatol. 
org/src/sm/ad-30-725-s001.pdf.
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CD13 Expression in Onychomatricoma: Association 
with Nail Matrix Onychodermis
Chan Seong Park, Ji-Hye Park, Dong-Youn Lee
Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Dear Editor:
Onychomatricoma is a rare peculiar tumor of the nail unit. 
It was originally reported to be a benign tumor of the nail 
matrix as its name implies. However, the terminology 
onychomatricoma may be a misnomer. Histologically, it is 
a fibroepithelial tumor consisting of epithelial and mesen-
chymal components. Thus, the concept of epithelial ony-
chogenic tumor with onychogenic mesenchyme was sug-
gested1.
Recently, we found the presence of onychodermis of 
Dongyoun, a specialized mesenchymal cell population 
below the the nail matrix and proximal nail bed demon-
strating CD10 expression2. Considering the components 
and location of onychomatricoma and its CD10 ex-
pression, we suggested the relation of onychomatricoma 
to onychodermis in the nail unit3. In addition, very re-
cently, we demonstrated that stronger CD13 expression 
was found in the mesenchyme containing onychofibro-
blasts below the nail matrix compared to that below the 
nail bed, suggesting that CD13 may be a marker for ony-
chofibroblasts within nail matrix onychodermis4.
In this study, to evaluate CD13 expression in onychoma-
tricoma and further elucidate the association of onycho-
matricoma with onychodermis in the nail unit we per-
formed CD 13 immunohistochemistry in three onychoma-
tricoma cases (one case was diagnosed at Samsung 
Medical Center [Fig. 1]. The other two cases were kind 
gifts from Dr. Robert Baran and from Catholic University 
Hospital, Seoul, Korea). Immunohistochemical staining 
was performed using the monoclonal antibody to CD13 
(1:50; clone 38C12; Abcam, Cambridge, UK).
H&E staining showed a fibroepithelial tumor with charac-
teristic digitations. The tumor was lined by nail matrix-like 
epithelium. The tumor cells consisted of spindle shaped 
nuclei. Immunohistochemically, CD13 was strongly ex-
pressed diffusely in dermal portion of onychomatricoma 
(Fig. 2). CD13 expression was very similar in thee onycho-
matricoma cases.
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Supplementary Fig. 1. Immunohistochemistry. (A) Positive immu-
nostaining for CD20 antigen denotes B lymphocytes; (B) Positive 
immunostaining for CD3 antigen denotes T lymphocytes; (C) 
Focally positive immunostaining for BCL2 antigen; (D) Focally 
positive immunostaining for BCL6 antigen; (E) Positive immuno-
staining for CD43 antigen denotes T lymphocytes (left, ×40 and 
right, ×100 magnification). 
